A reduced fixed dose of Tocilizumab 200 mg compared to 400 mg in patients with severe COVID-19 disease. OH&RM [Internet]. 29 septembrie 2023 [citat 24 iulie 2026];4(4):19-26. Disponibil la: https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/374